Regina E. Groves, a director at AtriCure Inc. (ATRC), made one open market sale of company shares in the past year, totaling about $90,300. Her most recent sale occurred on August 6, 2025. These sales rank 9,729th among 11,678 individual insiders, far below the average sale amount of $8.6 million across 6.4 transactions. Groves reported no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 6, 2025 | AtriCure, Inc. | $ATRC | GROVES REGINA E | Director | S | Common Stock | 2452 | $36.82 | 33,715.0000 | 48,879,604 | 6.78% | 0.01% |
| May 19, 2025 | AtriCure, Inc. | $ATRC | GROVES REGINA E | Director | A | Common Stock | 5401 | $0.00 | 36,167.0000 | 48,879,604 | 17.56% | 0.01% |
| May 15, 2025 | Fulgent Genetics, Inc. | $FLGT | GROVES REGINA E | Not found | A | Common Stock | 8982 | $0.00 | 16,982.0000 | 30,235,000 | 112.28% | 0.03% |
| May 16, 2024 | Fulgent Genetics, Inc. | $FLGT | GROVES REGINA E | Not found | A | Common Stock | 4000 | $0.00 | 8,000.0000 | 29,784,000 | 100.00% | 0.01% |
| May 16, 2024 | Fulgent Genetics, Inc. | $FLGT | GROVES REGINA E | Not found | A | Stock Option (Right to Buy) | 5481 | $0.00 | 5,481.0000 | 29,784,000 | 9999.99% | 0.02% |
| May 13, 2024 | AtriCure, Inc. | $ATRC | GROVES REGINA E | Director | A | Common Stock | 7788 | $0.00 | 30,766.0000 | 0 | 33.89% | 0.00% |
| May 25, 2023 | AtriCure, Inc. | $ATRC | GROVES REGINA E | Director | A | Common Stock | 3186 | $0.00 | 22,978.0000 | 0 | 16.10% | 0.00% |